UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.
News just out ... the US FDA plans to respond to MAPS/Lykos MDMA licensing application on August 11th
The FDA has granted the application priority review and has assigned a Prescription Drug User Fee Act (PDUFA) target action date of August 11, 2024 to make the review determination.